<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230506058100N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-16</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the analgesia effect of two types of abdominal block in children candidates for lower abdominal surgeries</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the analgesic effect of ultrasound-guided posterior quadratus lumborum block and ultrasound-guided ilioinguinal/iliohypogastric nerve block for pediatric lower abdominal surgery: A Prospective, randomized double-blinded study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72258</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, simple and individual randomization method is used.The Sealed Envelope site is used to generate random sequences. The website address is https://www.sealedenvelope.com.Each of the generated random sequences contains a unique code for hiding.First, using a computer program, such as Microsoft Excel or SAS, a sequence of random numbers will be generated Then, based on the randomization sequence, the participants will be assigned to 2 quadratus lumborum block groups and ilioinguinal/iliohipogaster block groups, And by using sealed envelopes, this allocation will be hidden, And the participants will be assigned to the appropriate groups according to the order of allocation, Blinding description: Blinding the patient: due to their condition and being unconscious, the patients are unaware of the treatment process and the patient's companion does not know which method was used for the disease.
Blinding of the outcome assessor: Data collectors will not be aware of the type of block and management during surgery and postoperative evaluation and will record all hemodynamic items, questionnaire interventions, and postoperative evaluations.</study_design>
      <phase>3</phase>
      <hc_freetext>pediatric candidates for lower abdominal surgeries.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:In group 1 or quadratus lumbarum group, where the posterior approach is selected, the patient will be lateralized and the side that is not operated on will be placed on the bed,The ultrasound probe will be placed in the midaxillary line between the rib edge and the iliac crest,After identifying the three layers of abdominal muscles, the probe is guided posteriorly until the external oblique and intertal oblique muscles reach the quadratus lumborum muscle.Then, needle number 22 is inserted with in-plane approach from front to back. The goal of the needle tip is to reach between the quadratus lumborum muscle and the erector spinea muscle, where the middle part of the thoracolumbar fascia reaches the posterior surface of the quadratus lumborum muscle.First, to confirm the correct location of the needle tip, 0.5cc of normal saline will be injected, and then 0.5cc/kg of ropivacaine 0.2% will be injected after negative aspiration. Intervention 2: Intervention group:In group 2 or ilioinguinal/iliohypogastric block group, in the supine position, we will place the ultrasound probe above the superior anterior sphincter, in alignment with the space between the navel and the superior anterior sphincter, so that three layers of muscle can be seen clearly,Then we find the ilioinguinal/iliohypogastric nerves in the form of two hypoechoic structures between the internal oblique muscle and the transverse abdominis and after preparation and drape and under sterile conditions, we insert the needle from the medial to the lateral side with an in-plane approach and near the nerves, first 0.5cc of normal saline will be injected to confirm the correct location, and after confirming the location and performing negative aspiration, 0.2cc/kg of ropivacaine 0.2% will be slowly injected around the nerve.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Tahereh Chavoshi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.193, Zafar st, Modares Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1919816766</zip>
        <telephone>+98 21 2304 6252</telephone>
        <email>chavoshi.t@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Tahereh Chavoshi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 193, Zafar st, Moddares Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1919816766</zip>
        <telephone>+98 21 2304 6252</telephone>
        <email>Chavoshi.t@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Candidate patients for unilateral inguinal hernia surgery and unilateral orchiopexy
In the age range of 4 to 12 years
Having informed consent from parents</inclusion_criteria>
      <agemin>4 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of surgery in the block area
Coagulation disorder
ASA class three and above
Opium use before surgery
Sensitivity to local anesthetics
Infection or redness at the injection site
Liver, kidney and heart diseases
Children with cerebral palsy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:In group 1 or quadratus lumbarum group, where the posterior approach is selected, the patient will be lateralized and the side that is not operated on will be placed on the bed,The ultrasound probe will be placed in the midaxillary line between the rib edge and the iliac crest,After identifying the three layers of abdominal muscles, the probe is guided posteriorly until the external oblique and intertal oblique muscles reach the quadratus lumborum muscle.Then, needle number 22 is inserted with in-plane approach from front to back. The goal of the needle tip is to reach between the quadratus lumborum muscle and the erector spinea muscle, where the middle part of the thoracolumbar fascia reaches the posterior surface of the quadratus lumborum muscle.First, to confirm the correct location of the needle tip, 0.5cc of normal saline will be injected, and then 0.5cc/kg of ropivacaine 0.2% will be injected after negative aspiration.</i_keyword>
      <i_keyword>Intervention group:In group 2 or ilioinguinal/iliohypogastric block group, in the supine position, we will place the ultrasound probe above the superior anterior sphincter, in alignment with the space between the navel and the superior anterior sphincter, so that three layers of muscle can be seen clearly,Then we find the ilioinguinal/iliohypogastric nerves in the form of two hypoechoic structures between the internal oblique muscle and the transverse abdominis and after preparation and drape and under sterile conditions, we insert the needle from the medial to the lateral side with an in-plane approach and near the nerves, first 0.5cc of normal saline will be injected to confirm the correct location, and after confirming the location and performing negative aspiration, 0.2cc/kg of ropivacaine 0.2% will be slowly injected around the nerve.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score. Timepoint: 30 minutes after transferring to the recovery room and 1, 2, 4, 6, 12, 24 hours after the operation. Method of measurement: Number based on Falcc Score.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-21</approval_date>
        <contact_name>کمیته اخلاق دانشگاه علوم پزشکی ایران</contact_name>
        <contact_address>Iran University of Medical Sciences, Next to Milad Tower; Shahid Hemat Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
